A health workers administers a dose of the Covishield vaccine at a vaccination center set up at Navyug School in New Delhi. (Photographer: Sumit Dayal/Bloomberg)
5 years ago
Jun 28, 2021
Follow the second Covid-19 wave in India and the vaccination efforts here.
India has found 48 cases of the Delta-plus Covid-19 variant across 11 states. Still, authorities say it is too early to tell whether it poses a significant threat like the Delta strain that drove the devastating second wave, swamping the healthcare system and overwhelming crematoriums.
The central government however, classified the Delta Plus as a “Variant of Concern”, which is more infectious and resistant to treatment. That’s the same degree of threat as the Delta mutation.
Tests are being conducted to check the effectiveness of the vaccines available in India — AstraZeneca’s Covishield and Bharat Biotech International Ltd.’s Covaxin — against the new variant.
